TRCT
GLSI icon

Tower Research Capital (TRC)’s Greenwich LifeSciences GLSI Stock Holding History

Tower Research Capital (TRC)’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.1K Buy
1,420
+264
+23% +$6.89K ﹤0.01% 3075
2025
Q4 		$24.3K Sell
1,156
-121
-9% -$1.27K ﹤0.01% 2959
2025
Q3 		$12.7K Sell
1,277
-1,986
-61% -$22.4K ﹤0.01% 3757
2025
Q2 		$29.6K Buy
3,263
+2,256
+224% +$21.5K ﹤0.01% 3405
2025
Q1 		$9.61K Sell
1,007
-41
-4% -$497 ﹤0.01% 3752
2024
Q4 		$11.8K Buy
1,048
+415
+66% +$5.56K ﹤0.01% 3679
2024
Q3 		$9.1K Buy
+633
New +$9.38K ﹤0.01% 3906
2024
Q2 		– Sell
-530
Closed -$10.6K – 5806
2024
Q1 		$10.6K Sell
530
-906
-63% -$11.2K ﹤0.01% 3684
2023
Q4 		$15.1K Buy
1,436
+140
+11% +$1.4K ﹤0.01% 3838
2023
Q3 		$11.5K Buy
1,296
+68
+6% +$639 ﹤0.01% 3992
2023
Q2 		$11.8K Buy
1,228
+127
+12% +$1.42K ﹤0.01% 3926
2023
Q1 		$15K Buy
1,101
+1,049
+2,017% +$16.6K ﹤0.01% 3785
2022
Q4 		$1K Buy
+52
New +$596 ﹤0.01% 5599
2022
Q3 		– Sell
-1,291
Closed -$11K – 6218
2022
Q2 		$11K Buy
1,291
+796
+161% +$9.12K ﹤0.01% 4372
2022
Q1 		$10K Sell
495
-401
-45% -$8.11K ﹤0.01% 4305
2021
Q4 		$22K Buy
896
+649
+263% +$21.7K ﹤0.01% 3562
2021
Q3 		$10K Sell
247
-41
-14% -$1.71K ﹤0.01% 4315
2021
Q2 		$13K Sell
288
-1,565
-84% -$59.2K ﹤0.01% 4221
2021
Q1 		$63K Buy
+1,853
New +$63.1K ﹤0.01% 2929

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Tower Research Capital (TRC)'s GLSI Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Greenwich LifeSciences (GLSI) stake by 23% in Q1 2026, buying an estimated $6.89K and bringing the position to 1,420 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3075.

Tower Research Capital (TRC) first reported a position in GLSI in Q1 2021 and has held it in 19 quarters since. The position peaked at $63K in Q1 2021. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Tower Research Capital (TRC) held 1,420 shares of Greenwich LifeSciences worth $34.1K as of Q1 2026.
  • Tower Research Capital (TRC) bought 264 Greenwich LifeSciences shares in Q1 2026, an estimated $6.89K.
  • Greenwich LifeSciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3075 holding.
  • Tower Research Capital (TRC) first reported a position in Greenwich LifeSciences in Q1 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Greenwich LifeSciences position peaked at $63K in Q1 2021.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.